Резултати от търсенето

Transparency

Прозрачност Takeda - Transparency Disclosure Report 2018 (PDF format, 184 Kb) Methodological Note 2018 (PDF format, 299 Kb)       ) Disclosures Archive ...
www.takeda.com/bg-bg/who-we-are/company-information/building-trust/transparency/

Interaction with Patients Organizations

Взаимодействие с пациентски организации Takeda - Patient Organizations Контакти: Takeda Bulgaria, 1680 София, бул. България 58, вх. С, ет. 6, офис 21 Interactions with Patient Organizations  ...
www.takeda.com/bg-bg/who-we-are/company-information/building-trust/interaction-with-patients-organizations/

Nycomed and Merck & Co., Inc., announce commercialization agreements for Daxas® in Europe and Canada

Nycomed and Merck & Co., Inc., announce commercialization agreements for Daxas® in Europe and Canada For further information Media: General phone: +41 44 555 15 10Beatrix Benz, phone:&n...
www.takeda.com/bg-bg/newsroom/news-releases/2010/nycomed-and-merck--co.-inc.-announce-commercialization-agreements-for-daxas-in-europe-and-canada/

Nycomed’s first quarter 2010 results confirm the direction

Nycomeds first quarter 2010 results confirm the direction Strong growth of Key Products and in emerging markets. Impact of pantoprazole's patent expiry in May 2009 as expected. Total net turnover d...
www.takeda.com/bg-bg/newsroom/news-releases/2010/nycomeds-first-quarter-2010-results-confirm-the-direction/

Website Privacy Notice

ДЕКЛАРАЦИЯ ЗА ЗАЩИТА НА ЛИЧНИТЕ ДАННИ НА УЕБСАЙТА НА ТАКЕДА Тази Декларация за защита на личните данни се отнася до уебсайта https://www.takeda.com/bg-bg Представителството на Такеда ГмбХ в Ре...
www.takeda.com/bg-bg/website-privacy-notice/